Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression
Authors
Keywords
Triple-negative breast cancer, Tumor-associated lymphatics, Tumor microenvironment, Taxane chemotherapy, Docetaxel, Lymphangiogenesis, Tissue engineered cell culture models, Cancer cell invasion, VEGFC/VEGFR3
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-06
DOI
10.1186/s12885-018-4619-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessing multiparametric drug response in tissue engineered tumor microenvironment models
- (2018) Alexandra R. Harris et al. METHODS
- Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4
- (2017) Lisa D. Volk-Draper et al. PLoS One
- A robust in vitro model for trans-lymphatic endothelial migration
- (2017) Yanbao Xiong et al. Scientific Reports
- Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
- (2016) Svetlana Skolekova et al. Cell Communication and Signaling
- Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms
- (2016) Kathryn M. Kingsmore et al. Integrative Biology
- Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium
- (2016) Yoko Dong et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
- (2016) Bruce A. Corliss et al. MICROCIRCULATION
- Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
- (2016) Dror Alishekevitz et al. Cell Reports
- Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1
- (2015) Kaoru Fujisaki et al. BREAST CANCER RESEARCH AND TREATMENT
- The Role of TLR4 in Chemotherapy-Driven Metastasis
- (2015) S. Ran CANCER RESEARCH
- Th2 Cytokines Inhibit Lymphangiogenesis
- (2015) Ira L. Savetsky et al. PLoS One
- Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
- (2014) L. Volk-Draper et al. CANCER RESEARCH
- A systematic review of bevacizumab efficacy in breast cancer
- (2014) Iben Kümler et al. CANCER TREATMENT REVIEWS
- CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment
- (2014) Shih-Wei Wang et al. CARCINOGENESIS
- Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer
- (2014) M.A. Socinski Current Oncology
- Emerging roles of lymphatic endothelium in regulating adaptive immunity
- (2014) Catherine M. Card et al. JOURNAL OF CLINICAL INVESTIGATION
- The Inflammatory Chemokine CCL5 and Cancer Progression
- (2014) Donatella Aldinucci et al. MEDIATORS OF INFLAMMATION
- Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages
- (2014) Kosuke Watari et al. PLoS One
- Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis
- (2014) Huan Yang et al. PLoS One
- TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling
- (2014) Hong Ji et al. Nature Communications
- The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer
- (2013) Carey K. Anders et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Bioinformatic analysis of chemokine (C-C motif) ligand 21 and SPARC-like protein 1 revealing their associations with drug resistance in ovarian cancer
- (2013) FUQIANG YIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
- (2013) S. Rajput et al. MOLECULAR CANCER THERAPEUTICS
- Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
- (2013) J. M. Balko et al. Cancer Discovery
- Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
- (2013) S. Goel et al. Cold Spring Harbor Perspectives in Medicine
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- Interstitial Flow in a 3D Microenvironment Increases Glioma Invasion by a CXCR4-Dependent Mechanism
- (2012) J. M. Munson et al. CANCER RESEARCH
- Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis
- (2012) Ramin Shayan et al. CLINICAL & EXPERIMENTAL METASTASIS
- Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature
- (2012) Jun Wang et al. MOLECULAR BIOLOGY REPORTS
- Tumor Cell Invasion Is Promoted by Interstitial Flow-Induced Matrix Priming by Stromal Fibroblasts
- (2011) A. C. Shieh et al. CANCER RESEARCH
- Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer
- (2011) Jianbo Xu et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular mechanisms of lymphangiogenesis in development and cancer
- (2011) Imke Albrecht et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance
- (2011) Rabab A A Mohammed et al. MODERN PATHOLOGY
- CCL5 Neutralization Restricts Cancer Growth and Potentiates the Targeting of PDGFRβ in Colorectal Carcinoma
- (2011) Béatrice Cambien et al. PLoS One
- Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer
- (2009) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
- (2009) M Szajnik et al. ONCOGENE
- Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages
- (2008) S. Kang et al. BLOOD
- Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
- (2008) P. Sini et al. CANCER RESEARCH
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
- (2008) Priya Rastogi et al. JOURNAL OF CLINICAL ONCOLOGY
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search